For research use only. Not for therapeutic Use.
Piroxicam-d3 (CAS: 942047-64-5), a premium pharmaceutical research compound designed for advanced anti-inflammatory and analgesic studies. As a deuterated analog of Piroxicam, it offers enhanced stability and improved pharmacokinetic properties. Piroxicam-d3 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for pain management and inflammatory conditions. Trusted by leading laboratories, Piroxicam-d3 is your go-to solution for cutting-edge anti-inflammatory research. Unlock new possibilities in pain and inflammation treatment with Piroxicam-d3, where innovation meets reliability.
Catalog Number | S000187 |
CAS Number | 942047-64-5 |
Molecular Formula | C15H10D3N3O4S |
Purity | ≥95% |
Target | COX |
IUPAC Name | 4-hydroxy-1,1-dioxo-N-pyridin-2-yl-2-(trideuteriomethyl)-1λ6,2-benzothiazine-3-carboxamide |
InChI | InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20)/i1D3 |
InChIKey | QYSPLQLAKJAUJT-FIBGUPNXSA-N |
SMILES | [2H]C([2H])([2H])N1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3 |
Reference | [1]. Kato M, et al. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes. J Pharm Pharmacol. 2001 Dec;53(12):1679-85. |